CN1284554C - Medicine for treating acute urticaria - Google Patents
Medicine for treating acute urticaria Download PDFInfo
- Publication number
- CN1284554C CN1284554C CNB2004100406045A CN200410040604A CN1284554C CN 1284554 C CN1284554 C CN 1284554C CN B2004100406045 A CNB2004100406045 A CN B2004100406045A CN 200410040604 A CN200410040604 A CN 200410040604A CN 1284554 C CN1284554 C CN 1284554C
- Authority
- CN
- China
- Prior art keywords
- shares
- present
- medicine
- acute urticaria
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The present invention discloses a medicine for treating acute urticaria, which is an oral medicinal liquid preparation prepared from 8 traditional Chinese medicines, such as 12 shares of long-noded pit viper, 15 shares of chrysanthemum, 6 shares of cicada slough, 12 shares of isatis root, 8 shares of ledebouriella root, 8 shares of mint, 12 shares of dyers woad leaf and 6 shares of mulberry leaf by weight parts. After the present invention is applied at clinic, the skin rashes of patients can completely regress, and new rashes can not appear. The present invention has the advantages of strong pertinence, favorable treating effects and small toxic or side effects. In addition, since the traditional Chinese medicines adopted in the formula of the present invention are usual traditional Chinese medicines with low price, the medicine of the present invention for treating acute urticaria also has the advantage of low treating expenses. The present invention is particularly suitable for treating acute urticaria diseases.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of the acute urticaria, belong to treatment urticaria medicine
Technical field.
Background technology:
Urticaria is a kind of common disease, and this sick cardinal symptom is a pruritus.Urticaria belongs to the anaphylactic disease scope, and its risk factor is more, thereby very difficult healing.According to clinical manifestation, urticaria can be divided into acute urticaria and chronic type urticaria again.The acute urticaria plays after being ill in a short period of time whole body and promptly produces the bulk infringement, and new rash occurs in batches, but it is also fast to disappear, and shows as whole body or exposure portion clinically and the flat erythra of welt sample occurs, and a little higher than surface takes on a red color or pink, has an itch or play is itched.And the morbidity of chronic type urticaria is more slow, and erythra just is a limitation, and aggravation gradually in 2～3 days can take place by whole body, and its clinical manifestation is the flat erythra of the general brightening pink of whole body, and this type is relatively more obstinate, usually outbreak repeatedly, and it is also slow to disappear.Urticaria has a strong impact on patient's ability to work and quality of life.The medicine of treatment urticaria is more at present, be commonly antianaphylactic Western medicine, though these medicines can play certain therapeutical effect to acute or chronic hives, but because these medicines just carry out pharmacological treatment at the general character of acute or chronic hives, and do not consider the characteristics of acute or chronic hives, so its curative effect still is not ideal enough; In addition, existing medicine also ubiquity expenses for medicine higher, the problem that toxic and side effects is bigger.Therefore, the result of use of the medicine of existing treatment acute urticaria disease still is not ideal.
Summary of the invention:
The objective of the invention is: provide that a kind of therapeutic effect is better, toxic and side effects is less and cost is lower specially at the medicine of the treatment acute urticaria of acute urticaria, to overcome the deficiencies in the prior art.
The present invention is achieved in that this medicine is made into oral liquid formulations by Agkistrodon, Flos Chrysanthemi, Periostracum Cicadae, Radix Isatidis, Radix Saposhnikoviae, Herba Menthae, Folium Isatidis and Folium Mori 8 flavor Chinese medicines, and each Chinese medicine proportioning by weight of distinguishing the flavor of is: 12 parts of Agkistrodons, 15 parts of Flos Chrysanthemis, 6 parts of Periostracum Cicadaes, 12 parts of Radix Isatidis, 8 parts of Radix Saposhnikoviaes, 8 parts of Herba Menthaes, 12 parts of Folium Isatidiss, 6 parts on Folium Mori.
In prescription of the present invention: Agkistrodon: its meridian distribution of property and flavor is sweet salty, and temperature is poisonous; It has wind-damp dispelling, saturating muscles and bones, the effect that arresting convulsion is jerked.Flos Chrysanthemi: be the head inflorescence of Compositae herbaceos perennial chrysanthemum; Its meridian distribution of property and flavor be sweet, bitter, be slightly cold, go into lung, Liver Channel; It has wind-dispelling heat-dissipating, nourishing the liver to improve visual acuity, the effect of heat-clearing and toxic substances removing.Periostracum Cicadae: be the shelling after the emergence of cicada Cryptotympana atrata Fabr.; Its another name has: Periostracum Cicadae, cicada skin, golden cover; The meridian distribution of property and flavor of this medicine is: sweet, cold, go into lung, Liver Channel; Has thin bone heat clearing away, lung qi dispersing rash, the effect of spasmolytic nebula removing.Radix Isatidis is a conventional Chinese medicine, and it is cold in nature, bitter in the mouth; The effect of tool heat-clearing and toxic substances removing, removing heat from blood sore-throat relieving.Radix Saposhnikoviae: its meridian distribution of property and flavor is: hot, sweet, tepor, go into bladder, liver, spleen channel; It has the effect of expelling pathogenic wind from the body surface, wind-damp dispelling, spasmolytic.Herba Menthae: its meridian distribution of property and flavor is: hot, cool, go into lung, Liver Channel; Effect with dispelling wind and heat pathogens, the clear sharp head, saturating dermexanthesis poison.Folium Isatidis: its meridian distribution of property and flavor is bitter, and is cold, goes into liver, the heart, stomach three warps; Have heat clearing away, separate attainment, the effect of removing heat from blood, hemostasis.Folium Mori: be the leaf of Moraceae defoliation small arbor plant mulberry, its meridian distribution of property and flavor is: sweet, bitter, cold, go into lung, Liver Channel; It has the effect of dispelling wind and heat pathogens, liver heat removing and eyesight improving.
After the present invention carries out rational formula with above-mentioned Chinese medicine commonly used, make the Chinese medicine of respectively distinguishing the flavor of to coordinate mutually to bring into play its property of medicine jointly, make the present invention have the effect of clearing away heat-damp and promoting diuresis, dispelling wind for relieving itching preferably.The present invention can make patient's erythra all disappear after clinical practice, and can not occur new rash again.Therefore, the present invention compares with the medicine of existing treatment urticaria, the advantage that the present invention is pointed by force, therapeutic effect is better, toxic and side effects is less, in addition because the Chinese medicine that is adopted in the prescription of the present invention all is common and cheap common Chinese, therefore adopt the present invention to treat the acute urticaria, also have the lower advantage of medical expense.The present invention is particularly suitable for treating the acute urticaria and uses.
The specific embodiment:
Embodiments of the invention; Get Agkistrodon 12 grams, Flos Chrysanthemi 15 grams, Periostracum Cicadae 6 grams, Radix Isatidis 12 grams, Radix Saposhnikoviae 8 grams, Herba Menthae 8 grams, Folium Isatidis 12 grams, Folium Mori 6 grams, and add after 1000 ml waters fully are mixed into medicinal liquid, the processing technology of oral liquid is endured medicinal liquid and is concentrated into 100 milliliters routinely again, can make oral liquid formulations of the present invention.The instructions about how to take medicine of oral liquid formulations are: every day 3 times, each 40～50 milliliters, use warm water delivery service.General 2～3 days is a course of treatment.
Be the clinical observation on the therapeutic effect analysis of adopting the present invention to treat 18 routine acute urticaria patients below, so that curative effect of the present invention is further described:
1, criterion of cure:
(1), recovery from illness in the recent period: skin rash and pruritus disappear, and do not see new survivor.
(2), produce effects: skin rash and pruritus obviously disappear, and idol has new life.
(3), take a turn for the better: skin rash and pruritus obviously disappear, but still show effect repeatedly sometimes.
(4), invalid: erythra and pruritus degree do not subtract after the medication, still outbreak repeatedly.
2, curative effect:
Adopt the present invention that 18 routine acute urticaria patients are treated, and after the observation of two weeks, its curative effect is as shown in the table:
| Type | The acute urticaria | |||
| Curative effect | Recovery from illness | Produce effects | Take a turn for the better | Invalid |
| 14 | 2 | 2 | 0 | |
Its cured person has 14 examples in last table, illustrates that cure rate of the present invention can reach 78%, and its effective percentage reaches 100%.
In addition, the present invention treats and viewing duration taking, and does not find that the patient has any bad clinical response.
Claims (1)
1, a kind of medicine for the treatment of the acute urticaria, it is characterized in that: this medicine proportioning by weight is as follows: 12 parts of Agkistrodons, 15 parts of Flos Chrysanthemis, 6 parts of Periostracum Cicadaes, 12 parts of Radix Isatidis, 8 parts of Radix Saposhnikoviaes, 8 parts of Herba Menthaes, 12 parts of Folium Isatidiss, 6 parts on Folium Mori, and with this 8 the flavor Chinese medicine be made into oral liquid formulations.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100406045A CN1284554C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating acute urticaria |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2004100406045A CN1284554C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating acute urticaria |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1615951A CN1615951A (en) | 2005-05-18 |
| CN1284554C true CN1284554C (en) | 2006-11-15 |
Family
ID=34763627
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2004100406045A Expired - Fee Related CN1284554C (en) | 2004-09-01 | 2004-09-01 | Medicine for treating acute urticaria |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1284554C (en) |
-
2004
- 2004-09-01 CN CNB2004100406045A patent/CN1284554C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1615951A (en) | 2005-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104352587B (en) | A kind of ointment for treating rhinitis | |
| CN104367796A (en) | Traditional Chinese medicine composition for treating mouth ulcer | |
| CN101919927B (en) | Spray for promoting scald healing | |
| CN102319397A (en) | Chinese medicinal decoction for treating chronic pelvic inflammatory disease with clystering method | |
| CN101129741A (en) | Liquid for clearing heat and promoting eruption | |
| CN101259242A (en) | Medicine for treating allergic rhinitis | |
| CN106581256B (en) | Traditional Chinese medicine composition for treating nasosinusitis, pharmaceutical preparation and preparation method thereof | |
| CN104840580A (en) | Traditional Chinese medicine for skin allergy nursing | |
| CN1284554C (en) | Medicine for treating acute urticaria | |
| CN105456887A (en) | Pharmaceutical for treating aplastic anemia | |
| CN101336990B (en) | Medicine for treating cholecystitis | |
| CN104825635A (en) | Traditional Chinese medicine composition for treating diabetic feet | |
| CN1245197C (en) | Chinese medicine preparation for treating coronary heart disease and viral myocarditis | |
| CN1314426C (en) | Medicine for treating chronic hives | |
| CN107951930A (en) | It is a kind of to be used to treat spray of allergic rhinitis and preparation method thereof | |
| CN104666824A (en) | Traditional Chinese medicinal composition for treating psoriasis | |
| CN104971210A (en) | External lotion for treating tinea pedis and preparation method thereof | |
| CN104758346A (en) | Medicine for treating migraine, as well as preparation method and preparation of medicine | |
| CN106581380A (en) | External preparation capable of promoting blood circulation to remove blood stasis and preparation method of external preparation | |
| CN104922488A (en) | Traditional Chinese medicine composition for preventing and curing Parkinson's disease or Parkinson's disease motor complications and preparing method and application thereof | |
| CN114917303A (en) | Traditional Chinese medicine composition for treating rhinitis and preparation method and application thereof | |
| CN113797277A (en) | Traditional Chinese medicine composition for preventing and treating nasal obstruction and nasal discharge and preparation method thereof | |
| CN105147861A (en) | Traditional Chinese medicinal composition and oral preparation for treating viral skin diseases and preparation method of oral preparation | |
| CN104225093A (en) | Traditional Chinese medicine composition for treating heat toxin flaming type diabetic foot | |
| CN115120680A (en) | Quick-acting traumatic injury medicinal liquor and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |